Thursday, March 23, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Low-Cost Paper-Based Diagnostic for Zika Virus

by Global Biodefense Staff
September 2, 2016
Zika Virus Diagnostics via Paper-Based Colorimetric Detection
Sensor Development and Zika Virus Detection
Sensors are embedded into paper discs and freeze-dried along with a cell-free transcription and translation system, to be deployed in the field as colorimetric diagnostics. In the diagnostic test, viral RNA is extracted, isothermally amplified, and used to rehydrate the freeze-dried sensors, resulting in a color change from yellow to purple in the presence of Zika RNA. Strain differentiation at single-base resolution is provided by a CRISPR-based module which connects to a secondary paper-based test that also provides colorimetric output. Courtesy of DTRA CBD.

Researchers from the Defense Threat Reduction Agency’s Joint Science and Technology Office (JSTO) are at the forefront of developing a paper-based diagnostic device to detect viral threats, such as Zika. Managed by JSTO’s Dr. Ilya Elashvili, the project is led by Dr. James J. Collins and his team from the Massachusetts Institute of Technology.

In a paper recently published in the journal Cell, the team details how they created a portable diagnostic platform that allows rapid, specific and low-cost detection of the Zika virus at clinically relevant concentrations. To achieve this outcome, the team merged two biotechnologies, which they previously developed.

Toehold Switches

The first of the two biotechnologies uses a riboregulator concept to construct programmable ribonucleic acid (RNA) sensors called toehold switches, which can be rationally designed to bind and sense virtually any RNA sequence. This sensing portion of the toehold is placed upstream of a ribosome binding site (RBS) to create a RBS-locking hairpin structure, which block RNA binding to ribosome and thereby prevents the translation of a downstream reporter protein.

When targeted, “trigger” RNA binds the toehold, peeling the hairpin and opening the blockade, allowing the RNA to bind to the ribosome and subsequent translation of the reporter protein (LacZ enzyme). This converts a yellow substrate to a purple product, indicating the presence of the virus.

Protein Expression Platform

The second technology involves a paper-based, freeze-dried, cell-free protein expression platform that allows for the deployment of these toehold switch sensors outside of a research laboratory by providing a sterile method for storage and distribution of genetic circuits at room temperature.

In order to achieve the sensitivity needed in the diagnostic tests, the researchers employed widely used nucleic acid sequence-based amplification (NASBA) to isothermally amplify extracted RNA. As a result, the researchers were able to develop a low-cost diagnostic platform for the detection of clinically relevant (low femtomolar) concentrations of Zika virus from infected monkey plasma.

Notably, there was no significant detection of the closely related Dengue virus.

CRISPR-Cas9 Genotyping

By employing a Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9-based module that can cut preprogrammed sequences in NASBA amplified product and thereby prevent reporting the selected target sequences, the researchers were able to discriminate different genotypes of Zika virus (i.e., American Zika virus from African Zika virus).

This diagnostic tool can be stored for more than a year at room temperature and does not require highly skilled personnel or expensive equipment to operate. This makes it suitable for current or emerging viral threats for deployed warfighters in low-resource areas, where detection and containment are critically needed.

Read more: Rapid, Low-Cost Detection of Zika Virus Using Programmable Biomolecular Components

Article based on original by Dr. Ilya Elashvili, DTRA. Edited for context and format by Global Biodefense.

Tags: CRISPRPOC DiagnosticsZika

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC